Zalicus starts Phase 2b rheumatoid arthritis trial - Mass High Tech

Zalicus starts Phase 2b rheumatoid arthritis trial Mass High Tech The planned 12-week clinical trial is expected to measure safety and efficacy of Synavive compared to a placebo in treating symptoms of rheumatoid arthritis. The company said in a news release that the trial results are expected in the second half of ... Zalicus Initiates Phase 2b Clinical Trial of Synavive in Rheumatoid ArthritisMarketWatch (press release) all 16 news articles »

Zalicus Initiates SYNERGY Trial - Zacks.com

Zalicus Initiates SYNERGY Trial Zacks.com by Jason Napodano, CFA Zalicus (ZLCS - Analyst Report) announced it has initiated a phase 2b clinical trial evaluating Synavive for the treatment of rheumatoid arthritis (RA). The trial, SYNERGY (SYNavivE for Reducing signs and sYmptoms of rheumatoid ... Zalicus starts Phase 2b rheumatoid arthritis trial, takes in .5MMass High Tech Zalicus Initiates SYNERGY TrialDaily Markets all 3 news articles »

Local Woman With Rheumatoid Arthritis Competes in 5K Race - Torrington Register Citizen

Local Woman With Rheumatoid Arthritis Competes in 5K Race Torrington Register Citizen Being active, doing Zumba and running and yoga helps allieviate the symptoms of Rheumatoid Arthritis, according to Seidman. “The more you move, the more you can move since it keeps 'the rheumatoids' from being able to stick together and settle in your ...

Rheumatoid Arthritis Research Progress - EmpowHer

Rheumatoid Arthritis Research Progress EmpowHer ... even when symptoms are not present. “The concept that remission in RA should require a disease-free state after the discontinuation of medication is debatable,” Shammas reported. There are many drugs available for treating rheumatoid arthritis, ... and more »